CAMRI in the News
- VIBRANT Clinical Trial: A Promising Phase 1 Trial of Novel Vaginal Live Biotherapeutics
The results of the VIBRANT Clinical Trial Phase 1 show promising success. CAMRI scientists, Dr. Jacques Ravel and Dr. Michael France, played a significant role in the creation of this study. - Sarah Brown, PhD, receives the 2025 Gottfried Family Women’s Health Fellowship Award
The Foundation for Women’s Wellness chose Dr. Sarah Brown to receive a 2025 Gottfried Family Women’s Health Fellowship Award. - Impact of a multi-strain L. crispatus-based vaginal synbiotic on the vaginal microbiome: a randomized placebo-controlled trial
Lead Scientist and CAMRI Director, Dr. Ravel’s milestone VS-01 Clinical Trial. - Historic One-Day Island-Wide Soil Microbiome Study Completed on CreteUniversity of Maryland School of Medicine Researchers Contribute to Unexpected Discoveries
Johanna Holm, an Assistant Professor at CAMRI and the lead author on this study, is featured in the Greek City Times for her team’s work on a historic one-day sampling of the soil in Crete. - Santé des femmes : le microbiote vaginal, un sujet crucial «sur les plans scientifique, sanitaire et sociétal»
CAMRI Director, Dr. Jacques Ravel, discusses the importance of vaginal microbiome research with the French Journal Libération. - Study Reveals Sexual Transmission of Bacterial Vaginosis
Rebecca Brotman, PhD, MPH, discusses new evidence that Bacterial Vaginosis could be sexually transmitted. - Microbiome interventions for children raise the ethical stakes
As the concern for microbiome intervention for children increases, Dr. Ravel weighs in with advice to parents about how to navigate these new products. - The secrets of an optimal vaginal microbiome
CAMRI Director Jacques Ravel is featured in Nature Portfolio, where he discusses his research on the vaginal microbiome. Nature features his innovative work with Seed. - Le microbiote vaginal, l’écosystème trop peu connu qui régule la santé des femmes
CAMRI Director Jacques Ravel, PhD, discusses the importance of the vaginal microbiome and its impact on health in French Journal Le Monde. - CAMRI: New Microbiome Research Center Established in School of Medicine
After a successful launch at the Mid-Atlantic Microbiome Meet-up in March, CAMRI is featured in UMB’s magazine Catalyst - Microbiome Science Company hones in on Vaginal Health with New Launch
Dr. Jacques Ravel discusses the Microbiome Company Seed’s new vaginal suppository, which was developed from his research over the past 15 years. A long overdue solution to a multitude of health issues including bacterial vaginosis (BV), yeast infections, urinary tract infections, and more. - US Researchers Call for Robust Studies into Dequalinium, a Bacterial Vaginosis Therapy Common in Europe
In an interview with Medscape, Dr. Rebecca Brotman, a faculty member at CAMRI, highlights the importance of a US clinical study on the bacterial vaginosis (BV) treatment, Dequalinium. - Here’s What you Need to Know About the Bacteria in your Vagina
CAMRI Director Jacques Ravel, PhD, explains what patients need to understand about the bacteria that make up their vaginal microbiome. - Unlocking the Secrets of the Microbiome
The New York Times highlights research on the vaginal microbiome conducted by CAMRI Director Jacques Ravel, PhD. - Vaginal Bacteria Guard Against Chlamydia InfectionMedium discusses the impact of research conducted by CAMRI Director Dr. Jacques Ravel which shows that certain species of vaginal Lactobacillus protect against Chlamydia infection, while others do not.
- What your vaginal microbiome can tell you about your overall health
CAMRI Faculty member Johanna Holm, PhD, discusses the significance of the understudied vaginal microbiome in an interview with Women’s Health Magazine, emphasizing its crucial role in women’s health including reducing the risk of Bacterial Vaginosis (BV) and preterm birth.